Sort
51,593 grants matching “hepatitis”
Cardiomyocyte Proliferation and Ventricular Morphogenesis
$437,038Henry M Sucov · University Of Southern California · R01 · FY2014 · HL
HCV NS4B: Translating molecular virology into novel antiviral therapies
$437,035Jeffrey S Glenn · Stanford University · R01 · FY2010 · AI
METABOLISM OF PYRUVATE ESTERS AND THIOESTERS
$437,026Case Western Reserve University · R01 · FY2000 · HL
A Clinical Trial to Prevent New Onset Diabetes After Transplantation
$437,024Akinlolu O Ojo · University Of Michigan At Ann Arbor · R01 · FY2013 · DK
Docosahexaenoic Acid Loaded Low-density Lipoproteins: A Novel Biologic Intervention for Hepatocellular Carcinoma.
$436,977Ian Ronald Corbin · Ut Southwestern Medical Center · R01 · FY2023 · CA
Cytapheresis Of Volunteer Donors (MRI 2003-054)
$436,968Dan Longo · National Institute On Aging · ZIC · FY2009 · AG
Use of a novel tricyclic Stk1 inhibitor to uncover molecular mechanism in clinically relevant strains of S. aureus
$436,960Heather B Miller · High Point University · R15 · FY2022 · GM
Investigation of Neoclerodanes as Novel Opioid Ligands
$436,907Thomas Edward Prisinzano · University Of Kansas Lawrence · R01 · FY2017 · DA
Human cytomegalovirus entry into epithelial and endothelial cells
$436,883David C. Johnson · Oregon Health & Science University · R01 · FY2012 · AI
Integration of HIV/AIDS, Viral Hepatitis, STD, and TB Programs
$436,858James W Gillan · Guam Department/ Health/Social Services · U52 · FY2016 · PS
Leveraging arginase biology against metabolic disease
$436,856Brian Jesse Debosch · Washington University · R01 · FY2023 · DK
EFFECTS OF MARIJUANA ON HIV AND VIRAL IMMUNITY
$436,833Michael D Roth · University Of California Los Angeles · R01 · FY2006 · DA
Simulation Modeling to Improve HIV/HCV Screening, Treatment and Care
$436,800Benjamin P Linas · Boston Medical Center · R01 · FY2012 · DA
HDL GENE DISCOVERY--GENOME WIDE EXPRESSION SCREENS
$436,758University Of Calif-Lawrenc Berkeley Lab · R01 · FY2000 · HL
Development of Advanced C-arm Cone-Beam CT for the Treatment of Liver Cancer
$436,757Xiaochuan Pan · University Of Chicago · R01 · FY2017 · CA
Carbon Monoxide and Mitochondrial Quality Control in Sepsis-induced Lung Injury
$436,747Claude A Piantadosi · Brigham And Women'S Hospital · P01 · FY2014 · HL
Biomarkers for Dysbiosis-Related HIV-Associated Cognitive Disorders among Persons Who Inject Drugs in Puerto Rico
$436,740Charles Wood · Lsu Health Sciences Center · R01 · FY2022 · DA
Receptor Cd74 integrates meta-inflammation in alcohol-associated liver disease
$436,731Kyle Poulsen · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · AA
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2019 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2020 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2021 · DK
CEACAM and Insulin Action
$436,728Sonia Michael Najjar · Ohio University Athens · R01 · FY2018 · DK
Re-engineering a human 3D liver tissue model for non-alcoholic fatty liver disease for drug screening
$436,677Mark T. Miedel · University Of Pittsburgh At Pittsburgh · UH2 · FY2022 · TR
1/3 Collaborative Research in HIV/AIDS, Alcohol, and Related Comorbidities (COMpAAAS) Tripartite: ART-CC, KP, and VA
$436,675Jonathan Sterne · University Of Bristol · U01 · FY2020 · AA
Chip-Based Diagnosis of Problematic Liver Tumors
$436,661Timothy J Yeatman · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2010 · CA